Search results
Showing 1351 to 1365 of 1515 results for patients and public
In development Reference number: GID-TA11556 Expected publication date: TBC
Mozafancogene autotemcel for treating Fanconi anaemia in people 1 to 17 years [ID12203]
In development Reference number: GID-TA11781 Expected publication date: TBC
In development Reference number: GID-TA11771 Expected publication date: TBC
In development Reference number: GID-TA11709 Expected publication date: TBC
Discontinued Reference number: GID-TA11338
In development Reference number: GID-TA11457 Expected publication date: TBC
In development Reference number: GID-TA11491 Expected publication date: TBC
In development Reference number: GID-TA11251 Expected publication date: TBC
Gantenerumab for treating early Alzheimer's disease [ID6142]
In development Reference number: GID-TA11269 Expected publication date: TBC
Nivolumab with chemotherapy for untreated unresectable or metastatic urothelial cancer [ID5102]
In development Reference number: GID-TA11010 Expected publication date: TBC
Terevalefim for treating delayed graft function after kidney transplant [ID1490]
Discontinued Reference number: GID-TA11098
Bimekizumab for treating active non-radiographic axial spondyloarthritis [ID4010]
Discontinued Reference number: GID-TA11151
Atezolizumab (Tecentriq) + bevacizumab (Avastin) + chemotherapy for ovarian cancer TS ID 10701
In development Reference number: GID-TA11157 Expected publication date: TBC
Masitinib for treating relapsed or refractory peripheral T-cell non-Hodgkin lymphoma [ID1125]
Discontinued Reference number: GID-TA11173
Lymphoma (diffuse large B-cell, untreated) – liposomal vincristine [ID1123]
Discontinued Reference number: GID-TA11208